Lnhc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LNHC, and when can generic versions of LNHC drugs launch?
LNHC has two approved drugs.
There are seventeen US patents protecting LNHC drugs.
There are ninety-five patent family members on LNHC drugs in twenty-nine countries and two supplementary protection certificates in two countries.
Summary for Lnhc
| International Patents: | 95 |
| US Patents: | 17 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Lnhc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lnhc | ZELSUVMI | berdazimer sodium | GEL;TOPICAL | 217424-001 | Jan 5, 2024 | RX | Yes | Yes | 10,265,334 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Lnhc | ZELSUVMI | berdazimer sodium | GEL;TOPICAL | 217424-001 | Jan 5, 2024 | RX | Yes | Yes | 10,376,538 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Lnhc | SITAVIG | acyclovir | TABLET;BUCCAL | 203791-001 | Apr 12, 2013 | RX | Yes | Yes | 8,747,896 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Lnhc | ZELSUVMI | berdazimer sodium | GEL;TOPICAL | 217424-001 | Jan 5, 2024 | RX | Yes | Yes | 11,285,098 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Lnhc | ZELSUVMI | berdazimer sodium | GEL;TOPICAL | 217424-001 | Jan 5, 2024 | RX | Yes | Yes | 10,258,564 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Lnhc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Slovenia | 1998750 | ⤷ Try a Trial |
| European Patent Office | 2961382 | ⤷ Try a Trial |
| China | 102652016 | ⤷ Try a Trial |
| Canada | 2647123 | ⤷ Try a Trial |
| Canada | 2606565 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Lnhc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0809498 | 10C0038 | France | ⤷ Try a Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
| 0809498 | SPC/GB10/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
